IL6 and Huntington disease: In conclusion, our data reveal that a constitutive KO of IL-6, which is normally expressed in both neurons and glia in the CNS [27], including in the striatum [28], exacerbates several HD-related behavioral phenotypes in the R6/2 exon1 mHTT model of HD.